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Background
Stress perfusion cardiac MRI (CMR) with a high relaxiv-
ity blood-pool contrast agent should allow for improved
quantification of myocardial perfusion and myocardium
blood volume in patients with coronary artery disease
(CAD). In the current study, we sought to evaluate the
diagnostic performance and image quality of stress per-
fusion CMR using the intravascular contrast agent gado-
foveset trisodium and regadenoson stress agent in
patients with suspected CAD.
Methods
Patients with suspected CAD were identified based on
referral for cardiac catheterization and/or stress testing
and recruited to undergo CMR at 1.5T (MAGNETOM
Avanto, Siemens, Erlangen, Germany). The CMR proto-
col included stress perfusion imaging using 5 ml intrave-
nous (IV) regadenoson (Lexiscan, Astellas US LLC) as
the stress agent, and the effects of regadenoson were
reversed with 50 mg IV aminophylline following the
completion of stress imaging. Left ventricular (LV) base,
mid, and apex short axis cine images were acquired in
identical slice positions during first pass using 5 ml IV
gadofoveset trisodium contrast (Ablavar, Lantheus) at
both stress and rest. Perfusion images were reviewed
and sensitivity and specificity for CAD diagnosis were
calculated. Overall image quality, image noise, and pre-
sence of artifact for each patient scan were graded on a
scale of 1 - poor to 5 - excellent.In addition to the per-
fusion scan, the MRI protocol included pre- and post-
contrast 2D Modified Look-Locker (MOLLI) measure-
ment of T1 which were used to calculate the myocardial
blood volume (in ml/100g of tissue).
Results
Stress perfusion CMR was performed on n = 20 subjects
(age: 61.8 ± 12.2 years, M:F = 13:7). Seventeen patients
(85%) had cardiac catheterization within 1 month of
CMR, while 2 patients had a positive nuclear stress test,
and 1 patient had positive stress echocardiography.
Seven catheterized patients (41%) had ≥ 70% occlusion
of at least one of the left anterior descending, left cir-
cumflex, or right main coronary artery. The sensitivity/
specificity for diagnosing CAD on a per-patient basis
was 0.8/0.5. Qualitative assessment revealed good image
quality (4.38 ± 0.46), low noise (4.45 ± 0.28), and little
artifact (4.28 ± 0.38).For pre-/post- stress perfusion MRI
in our cohort, the average ΔR1
myo was 1.23 ± 0.24 msec-
1 while the average ΔR1
blood was 3.63 ± 0.54 msec-1. As
shown in figure 1, the slope of the linear regression
between ΔR1
myo and ΔR1
blood was a = 0.34 suggesting
that gadofoveset trisodium does not behave as a true
intravascular agent in the myocardium.
Conclusions
Stress perfusion CMR using regadenoson and gadofoveset
trisodium provides diagnostic quality images with sensitiv-
ity for CAD diagnosis comparable to published results.
Our results suggest that gadofoveset trisodium does not
behave as a true intravascular agent in the myocardium
and thus a quantification of myocardial intravascular
blood volume (and hence a calculated coronary flow
reserve) cannot be calculated using the approach.
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